Acute lymphoblastic leukemia (ALL) patients comprise a highly immunocompromised group
due to factors associated either with the treatment or the disease itself. Invasive mold …

Background Despite fungal prophylaxis, invasive mold infections (IMIs) are a significant
cause of morbidity and mortality in patients with acute myeloid leukemia (AML) receiving …

Background Mold-active primary antifungal prophylaxis (PAP) is routinely recommended in
neutropenic patients with newly diagnosed acute myeloid leukemia (AML) or high-risk …

Objectives: Invasive mold infections (IMI) are an important cause of morbidity and mortality in
patients with hematological malignancies. Cumulative incidence numbers vary greatly …

Background Multiple factors influence the choice of primary antifungal prophylaxis (PAP) in
patients with acute myeloid leukemia (AML) undergoing remission induction chemotherapy …

Invasive mold infections (IMIs) can complicate intensive myelosuppressive chemotherapy for
hematological malignancies, particularly acute leukemia. As allogeneic hematopoietic SCT …

Burden of invasive mold disease in patients with acute myelogenous leukemia and in stem cell
transplant recipients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Background There are limited real-life data on isavuconazole prophylaxis and treatment of
invasive mold infections (IMI) in hematological patients and allogeneic hematopoietic cell …

Background Patients with acute leukaemia have a high incidence of fungal infections. This
has primarily been shown in acute myeloid leukaemia and is different for acute …

Abstract Introduction: Invasive fungal infections (IFIs) are important causes of morbidity and
mortality among patients (pts) with acute myeloid leukemia (AML) or myelodysplastic …